cab-m7 protein, Zea mays

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2017
01219912017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND/AIMS Approximately 20-40% of patients with gastroesophageal reflux disease (GERD) are refractory to proton pump… (More)
Is this relevant?
2015
2015
Acid-related diseases (ARD) including gatroesophageal reflux disease (GERD) and peptic ulcer disease (PUD) are treated by acid… (More)
Is this relevant?
2011
2011
Inhibition of the gastric H,K-ATPase by the potassium-competitive acid blocker (P-CAB) 1-[5-(2-fluorophenyl)-1-(pyridin-3… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2011
2011
TAK-438 is a novel potassium-competitive acid blocker (P-CAB) type antisecretory agent that reversibly inhibits gastric H+, K… (More)
Is this relevant?
2007
2007
After treatment of millions of patients suffering from gastroesophageal reflux disease (GERD) and other acid-related ailments… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 2
  • figure 5
Is this relevant?
1991
1991
The steady-state levels of mRNA produced by 14 genes encoding members of the tomtato chlorophyll a/b binding protein family were… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?